Any Organ Any Body
Website presents technology being developed by an existing biomedical company, Pure Transplant Solutions.
PTS has developed a proprietary immunotherapeutic protein integrated with a medical device called the selective HLA Antibody Removal Column (ARC™) for use in a novel selective antibody removal therapy.
The ARC therapy is similar to a dialysis therapy but instead of filtering the blood of byproducts for a failing kidney, the anti-HLA antibodies are specifically filtered and removed from the serum fraction of the blood, to allow for unacceptably matched organs to be transplanted, making possible the donation of an organ of any tissue type to a patient of any tissue type – effectively “Any Organ, Any Body”.
PTS has launched a crowdfunding campaign to raise awareness and funds for the ARC™ technology.
Your contributions will help fund the expense of clinical development.
You can help remove the barriers to organ transplantation and improve the lives of millions of transplant patients globally: